Vapotherm Future Growth
Future criteria checks 1/6
Vapotherm is forecast to grow earnings and revenue by 25.5% and 14.9% per annum respectively while EPS is expected to grow by 80.9% per annum.
Key information
25.5%
Earnings growth rate
80.9%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 14.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 Nov 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 94 | -37 | N/A | N/A | 2 |
12/31/2024 | 81 | -46 | N/A | N/A | 3 |
12/31/2023 | 70 | -59 | N/A | N/A | 3 |
9/30/2023 | 68 | -69 | -37 | -31 | N/A |
6/30/2023 | 66 | -81 | -54 | -47 | N/A |
3/31/2023 | 63 | -108 | -69 | -60 | N/A |
12/31/2022 | 67 | -113 | -92 | -80 | N/A |
9/30/2022 | 70 | -110 | -95 | -85 | N/A |
6/30/2022 | 95 | -98 | -84 | -75 | N/A |
3/31/2022 | 103 | -72 | -73 | -66 | N/A |
12/31/2021 | 113 | -60 | -61 | -55 | N/A |
9/30/2021 | 132 | -58 | -55 | -47 | N/A |
6/30/2021 | 124 | -57 | -54 | -45 | N/A |
3/31/2021 | 139 | -48 | -59 | -49 | N/A |
12/31/2020 | 126 | -52 | -49 | -39 | N/A |
9/30/2020 | 98 | -47 | -51 | -43 | N/A |
6/30/2020 | 78 | -47 | -52 | -45 | N/A |
3/31/2020 | 55 | -52 | -46 | -41 | N/A |
12/31/2019 | 48 | -51 | -44 | -40 | N/A |
9/30/2019 | 47 | -51 | -44 | -40 | N/A |
6/30/2019 | 45 | -48 | -47 | -42 | N/A |
3/31/2019 | 44 | -47 | -44 | -39 | N/A |
12/31/2018 | 42 | -43 | -45 | -40 | N/A |
9/30/2018 | 41 | -39 | -43 | -36 | N/A |
6/30/2018 | 40 | -37 | -41 | -34 | N/A |
3/31/2018 | 38 | -33 | -40 | -33 | N/A |
12/31/2017 | 36 | -31 | -35 | -29 | N/A |
12/31/2016 | 30 | -23 | N/A | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VA20 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VA20 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VA20 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VA20's revenue (14.9% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: VA20's revenue (14.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VA20's Return on Equity is forecast to be high in 3 years time